Announced Thu, 30 Apr · 15:37 IST
Laurus Labs to voluntarily close German step-down subsidiary Laurus Generics GmbH
Strategic Transactions View source PDF
LAURUSLABS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+5.1%1-day move
₹1106.45
prior close
₹1102.20
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+2.3+4.9+4.2+3.8+5.1+6.6+8.8+10.7+14.8+15.8+22.9+29.2+38.1—
Up moveDown movePending
AI summary
Laurus Labs' Board has approved the voluntary closure of its step-down wholly owned subsidiary, Laurus Generics GmbH (Germany), subject to regulatory approvals. The subsidiary is not material, reported nil revenue for FY ended March 31, 2026, and had a negative net worth of Euro 10.53 lakh. The company stated the closure will have no material impact on its financials or operations.
Likely market impact
Negligible impact on shareholders; the closed unit had zero revenue and negative net worth, making this a routine non-core cleanup.